Literature DB >> 16414260

Surgical treatment of ovarian cancer in different hospital categories--a prospective nation-wide study in Finland.

Salla Kumpulainen1, Tapio Kuoppala, Arto Leminen, Jorma Penttinen, Ulla Puistola, Eero Pukkala, Risto Sankila, Juha Mäkinen, Seija Grénman.   

Abstract

This prospective nation-wide study was performed to evaluate the effect of hospital category and subspeciality training on surgical treatment of ovarian cancer. Data were obtained from a questionnaire filled in by the operating unit, and from the surgical and histopathology reports. The survey included 307 patients. Half of them were operated in the university hospitals where gynaecologic oncologists performed 72% of the operations. This was the case in only 4% and 19% in the central and district hospitals, respectively. In university hospitals, pelvic lymphadenectomy was performed in 88%, and para-aortic lymphadenectomy in 73%, of the patients with stage I disease. The corresponding figures ranged from 11% to 21% in central and district hospitals. For stage III patients operated by gynaecologic oncologists, the estimated odds ratio for no macroscopic tumour was 3.0 times higher (95% CI 1.2-7.5) than for those operated by general gynaecologists. These results favour centralisation of surgical treatment of ovarian cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16414260     DOI: 10.1016/j.ejca.2005.09.029

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

Review 1.  Is It Time to Centralize Ovarian Cancer Care in the United States?

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Ginger J Gardner; Douglas A Levine; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; William P Tew; Evis Sala; Yulia Lakhman; Hebert A Vargas Alvarez; Debra M Sarasohn; Svetlana Mironov; Nadeem R Abu-Rustum; Dennis S Chi
Journal:  Ann Surg Oncol       Date:  2015-10-28       Impact factor: 5.344

2.  Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.

Authors:  A K Sinno; X Li; R E Thompson; E J Tanner; K L Levinson; R L Stone; S M Temkin; A N Fader; D S Chi; K Long Roche
Journal:  Gynecol Oncol       Date:  2017-03-30       Impact factor: 5.482

3.  If the Mountain Does Not Come to Mohammad: The Significance of Guest Operations for Early Stage Ovarian Cancer.

Authors:  Inge T A Peters; Carolien van Haaften; J Baptist Trimbos
Journal:  J Gynecol Surg       Date:  2014-10-01

4.  XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent way.

Authors:  Ruili Huang; Lijuan Zhu; Yali Zhang
Journal:  Cancer Cell Int       Date:  2020-09-04       Impact factor: 5.722

5.  What underlies the observed hospital volume-outcome relationship?

Authors:  Marius Huguet; Xavier Joutard; Isabelle Ray-Coquard; Lionel Perrier
Journal:  BMC Health Serv Res       Date:  2022-01-14       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.